A targeted drug delivery system based on E. coli ghost for inhibiting non-Hodgkin’s lymphoma-Reference-Cited by-同舟云学术

A targeted drug delivery system based on E. coli ghost for inhibiting non-Hodgkin’s lymphoma

Published:2023-12 Issue: Volume:678 Page:132504
ISSN:0927-7757
Container-title:Colloids and Surfaces A: Physicochemical and Engineering Aspects
language:en
Short-container-title:Colloids and Surfaces A: Physicochemical and Engineering Aspects

Author:

Li Xiaoqi,Wang Liyuan,Zhang Yu,Zhai Yongqing,Wang Long,Li Xinglan,Wang Lijuan,Zhu Yanxi

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry

Reference37 articles.

1. Doxorubicin-loaded micelles in tumor cell-specific chemotherapy;Almajidi;Environ. Res.,2023

2. Drug development of lyso-thermosensitive liposomal doxorubicin: combining hyperthermia and thermosensitive drug delivery;Borys;Adv. Drug Deliv. Rev.,2021

3. A dual-prodrug nanoparticle based on chitosan oligosaccharide for enhanced tumor-targeted drug delivery;Chen;Colloids Surf. A Physicochem. Eng. Asp.,2021

4. Pegylated liposomal doxorubicin-induced hand-foot syndrome predicted by serum metabolomic profiling and prevented by calcium dobesilate;Song;J. Am. Acad. Dermatol.,2022

5. Reactive oxygen species-mediated inflammation and apoptosis in hand-foot syndrome induced by PEGylated liposomal doxorubicin;Hu;Int. J. Nanomed.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel strategies for modulating the gut microbiome for cancer therapy;Advanced Drug Delivery Reviews;2024-07

2. Drug-Loaded Biomimetic Carriers for Non-Hodgkin’s Lymphoma Therapy: Advances and Perspective;ACS Biomaterials Science & Engineering;2024-01-31